GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...
Tags: Glaxosmithkline, Vaccines Business
The University of Washington (UW), University of Texas Medical Branch (UTMB) at Galveston, US, and Kineta have been granted a $8.1m biodefense award by the National Institute of Allergy and Infectious Diseases (NIAID). The funding aims to ...
Tags: the National Institute of Allergy and Infectious Diseases
The US Department of Defense(DoD)has extended the period of a temporary stop-work order with respect to Tekmira Pharmaceuticals TKM-Ebola program. Tekmira is expecting to receive notification from DoD,regarding stop-work order contract ...
Tags: Tekmira Temporary, Tekmira Pharmaceuticals, TKM-Ebola program, DoD
A 5 year $5.4m grant has been awarded to Profectus BioSciences and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston to support the development of a Vesicular Stomatitis virus-vectored vaccine ...
Tags: Trivalent Vaccine, rVSV-vectored filovirus, Ebola and Marburg Viruses